
In early February, Clarient Inc announced the commercial launch of its Insight Dx Pulmotype test that helps pathologists classify specific types of lung cancer so physicians can prescribe the most effective therapies.

In early February, Clarient Inc announced the commercial launch of its Insight Dx Pulmotype test that helps pathologists classify specific types of lung cancer so physicians can prescribe the most effective therapies.

New evidence presented at the annual meeting of the Society of Gynecologic Oncologists suggests that Gardasil, a vaccine that prevents cervical cancer, also reduces the likelihood of recurrence after surgery by 40%.

A novel blood test identifies PAM4 (or clivatuzumab), an antigen that is present in almost 90% of pancreatic cancers and precancers.